Cargando…

Early abnormal liver enzyme levels may increase the prevalence of human cytomegalovirus antigenaemia after hematopoietic stem cell transplantation

OBJECTIVE: Human cytomegalovirus (HCMV) infection is common after bone marrow transplantation (BMT), and it increases morbidity and mortality for transplant recipients. HCMV infection may cause hepatitis and elevate the liver enzymes aspartate transferase (AST) and alanine transferase (ALT). This st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Baning, Zhao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536655/ https://www.ncbi.nlm.nih.gov/pubmed/28415934 http://dx.doi.org/10.1177/0300060516689013

Ejemplares similares

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
por: Dieamant, Débora C, et al.
Publicado: (2013)

Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
por: Irvine, Michael A., et al.
Publicado: (2016)

An investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys
por: Cano, Jorge, et al.
Publicado: (2015)

Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation
por: Kim, Joo Young, et al.
Publicado: (2020)

Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda
por: Nakanjako, Damalie, et al.
Publicado: (2011)

Clinical and financial impacts of abnormal liver biochemistry after liver transplantation
por: Lim, Dee Zhen, et al.
Publicado: (2023)

Serum immunoglobulin levels in primary liver cancer: relationship to underlying cirrhosis and hepatitis-B (surface) antigenaemia.
por: Ipp, T., et al.
Publicado: (1975)

Late cytomegalovirus infection after hematopoietic stem cell transplantation: case reports
por: Pinheiro, Sâmara Grapiuna, et al.
Publicado: (2013)

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
por: Ong, Shin-Yeu, et al.
Publicado: (2015)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Stern, Lauren, et al.
Publicado: (2019)

High Prevalence of Cryptococcal Antigenaemia and Disseminated Cryptococcal Disease Amongst Patients with Advanced HIV Disease in Pune, India
por: Kumar Medisetty, Mahender, et al.
Publicado: (2017)

District and sub-district analysis of cryptococcal antigenaemia prevalence and specimen positivity in KwaZulu-Natal, South Africa
por: Cassim, Naseem, et al.
Publicado: (2018)

Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India
por: Acharya, Shrikala, et al.
Publicado: (2023)

Endogenous retrovirus type W GAG and ENV antigenaemia in serum of schizophrenic patients
por: Bernard, Corinne, et al.
Publicado: (2009)

Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation
por: Jaing, Tang-Her, et al.
Publicado: (2019)

Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
por: Cho, Sung-Yeon, et al.
Publicado: (2019)

Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years
por: Diaz, Laura, et al.
Publicado: (2020)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
por: Mardani, Masoud, et al.
Publicado: (2020)

Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
por: Cui, Jiaqi, et al.
Publicado: (2022)

The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients
por: Zakhour, Johnny, et al.
Publicado: (2022)

Impact of Basic Lymphedema Management and Antifilarial Treatment on Acute Dermatolymphangioadenitis Episodes and Filarial Antigenaemia
por: El-Nahas, HA, et al.
Publicado: (2011)

Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
por: Stolk, Wilma A., et al.
Publicado: (2022)

Case Report: Liver as a Source of Hematopoietic Stem Cells After Liver Transplantation Following Hematopoietic Stem Cell Transplantation
por: Jarmoliński, Tomasz, et al.
Publicado: (2022)

Peripheral blood lymphocyte responses to cytomegalovirus seropositivity after allogeneic-hematopoietic stem cell transplantation
por: Zhang, Jiexin, et al.
Publicado: (2018)

Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Furuno, Jon P, et al.
Publicado: (2017)

Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation
por: Bernshtein, Biana, et al.
Publicado: (2021)

Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation
por: Zhou, Xinyi, et al.
Publicado: (2021)

Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
por: Li, Shan-shan, et al.
Publicado: (2022)

Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation
por: Sato, Kazuya, et al.
Publicado: (2022)

Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity
por: del Rosal, Teresa, et al.
Publicado: (2022)

Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation
por: Xia, Jintao, et al.
Publicado: (2022)

Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
por: Wang, Xiaona, et al.
Publicado: (2023)

Abnormal Liver Enzymes during the First Two Months of Liver Transplantation
por: Geramizadeh, B
Publicado: (2015)

P1617: CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS DRUG RESISTANCE GENE MUTATIONS IN CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: yang, D., et al.
Publicado: (2022)

Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation
por: Borchers, Sylvia, et al.
Publicado: (2012)

Letermovir for Cytomegalovirus Prevention in Patients Undergoing Hematopoietic Cell Transplantation
por: Daniels, Kori, et al.
Publicado: (2019)

Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil
por: Borges, Moara Alves Santa Bárbara, et al.
Publicado: (2019)

Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
por: Oulton, Tate, et al.
Publicado: (2022)

Quantification of Cytomegalovirus Glycoprotein Bn DNA in Hematopoietic Stem Cell Transplant Recipients by Real-time PCR
por: Zhang, Xuan, et al.
Publicado: (2012)

Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy
por: Kim, Tark, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5tgv4m128vjkc06p3fpdiukskp